Navigation Links
UCSF Researchers Use New Tools to Move in on Cancer Susceptibility Genes
Date:1/12/2009

UCSF researchers have used a new strategy to study inherited susceptibility for skin cancer in mice. In the process, they have identified a network of genes that may play a key role in controlling this susceptibility. The technique, the scientists say, could be used to identify such genes in human cancers.

(PRWEB) January 12, 2009 -- UCSF researchers have used a new strategy to study inherited susceptibility for skin cancer in mice. In the process, they have identified a network of genes that may play a key role in controlling this susceptibility. The technique, the scientists say, could be used to identify such genes in human cancers.

The finding, reported in the Jan. 11, 2009 Advance Online Publication of Nature, builds on a promising technique called genetic network analysis, which allows scientists to analyze complex systems. The technique has been used to study heritable traits such as obesity and to study the workings of organs such as the human brain. However, it has never been used in cancer genetics, due to the complexity in studying how genetic differences influence whether an organism will develop cancer.

"This is the first time these techniques have been used to analyze cancer susceptibility. Using this framework, these methods should be applicable in many different areas of cancer research or other types of heritable diseases that thus far have been difficult to study," says senior study author Allan Balmain, PhD, UCSF professor of biochemistry and Barbara Bass Bakar Distinguished Professor in Cancer Genetics at the UCSF Helen Diller Family Comprehensive Cancer Center.

Genetic network analysis produces a map of how key genes interact with each other to control physiological functions and structures. Applying this tool to cancer research opens a new window on the disease.

"There are rare mutations that strongly predispose people to getting a type of cancer, but most cancers are caused by a combination of environmental influences and moderately influential differences in the DNA that an individual is born with. The kinds of changes we are studying are not instant tickets to cancer but are predispositions. This is something that is much harder to track but could be very useful in the future realm of personalized medicine," says David Quigley, MA, the first author on the paper and the lead computational expert on the project.

Significantly, the UCSF researchers used only a personal computer to map out the relevant gene networks. Previous studies using this technique have required supercomputers or other forms of high-powered computing. Reducing computing requirements should allow many more laboratories to use genetic network analysis techniques.

In their study, the researchers bred together laboratory mice of the species Mus Musculus with wild mice of the species Mus Spretus. M. Musculus has strong susceptibility to skin cancer and M. Spretus has strong resistance to skin cancer.

The researchers attempted to induce skin cancer in the mixed offspring of these mice and then examined how genetic control of gene expression affected their tumor susceptibility. By examining genetic differences between mice who did and did not develop skin cancer, the researchers identified the Vitamin D Receptor as a candidate master regulator for skin cancer in the mice.

Vitamin D levels in the blood have long been recognized as having an influence on skin functions and susceptibility to inflammatory diseases in humans and mice. Diminished Vitamin D levels or a faulty Vitamin D Receptor gene have also been associated with the propensity for various types of cancer in people and mice.

"Now we have shown Vdr can be linked to skin cancer in mice using genetic network analysis methods," says Balmain. Because man and mouse share significant similarities in cancer genetics and cancer development, he says, gene candidates for cancer in mice could directly translate into gene candidates for cancer susceptibility in humans.

Genetic networks comprise dozens or hundreds of genes that interact by switching on and off in response to internal stimuli, external stimuli, or some combination of both.

This switching process, called gene expression, has been extremely difficult to measure and assess due to the sheer numerical complexity of the process. In part, this complexity explains why most cancer genetics research to date has focused on identifying clear interactions between single genes and a specific type of cancer. However, these approaches so far have not been sufficient to explain how gene expression impacts susceptibility to many types of cancers.

The researchers also used their technique to identify gene networks that appeared to represent either structural or functional components of the skin, such as skin-resident cell types (hair follicles, muscle, melanocytes, haematopoietic cells) and physiological (for example, inflammation) or cellular (for example, cell cycle) functions.

They discovered that a gene called Lgr5 that is expressed in stem cells of the skin and intestine is a candidate master regulator for the development of hair follicles. In the context of skin cancer, hair follicle development may be important because the hair follicle is a continuously regenerating organ system. Scientists have used this system as a model for studying cancer development in different organs.

According to the researchers, their research approach could easily be replicated for genetic network analysis of virtually any type of moderately or partially heritable cancer, as well as for other inherited diseases that do not have single-gene binary switches and result from more complex genetic interactions. Potential research candidates could include lung, breast or colon cancers, as well as inherited diseases outside the realm of cancer such as autoimmune disorders.

Additional co-authors of the paper were: Minh D. To of the UCSF Comprehensive Cancer Center and the Department of Surgery; Jesus Perez-Losada of the Departamento de Medicina, Facultad de Medicina, Universidad de Salamanca; Facundo G. Pelorosso of the UCSF Comprehensive Cancer Center; Jian-Hua Mao of the UCSF Comprehensive Cancer Center and the Life Sciences Division, Lawrence Berkeley National Laboratory, University of California, Berkeley; Hiroki Nagase of the Roswell Park Cancer Institute and Nihon University, and David Ginzinger of the UCSF Comprehensive Cancer Center.

The study was funded primarily by the National Cancer Institute. Additional funding for the research or personnel involved in the research came from the Sandler Foundation postdoctoral research fellowship program, the Spanish Ministerio de Educacion y Ciencia, the European Community, the Fondo de Investigaciones Sanitarias and Junta de Castilla y Leon.

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.

Contact:
Jennifer O'Brien
(415) 476-2557
Web: www.ucsf.edu

###

Read the full story at http://www.prweb.com/releases/UCSF/Cancer_Susceptibility/prweb1841484.htm


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
4. Bipolar disorder relapses halved by Melbourne researchers
5. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
6. High and mighty: first common height gene identified by researchers behind obesity gene finding
7. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
8. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
9. Researchers develop long-lasting growth hormone
10. Jefferson immunology researchers halt lethal rabies infection in brain
11. Purdue researchers develop technology to detect cancer by scanning surface veins
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UCSF Researchers Use New Tools to Move in on Cancer Susceptibility Genes 
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of ... Farma Brasil as the company,s second affiliate in Latin America . ... ... Manager of Astellas Farma Colombia ... ...
Breaking Medicine Technology: